{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:13:01Z","timestamp":1790835181906,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["JANUSK21D0"],"award-info":[{"award-number":["JANUSK21D0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcf.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T19:37:34Z","timestamp":1684352254000},"page":"665-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participation"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-6449","authenticated-orcid":false,"given":"Megan N","family":"Januska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8119-7559","authenticated-orcid":false,"given":"Elinor","family":"Langfelder-Schwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Plachta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-3251","authenticated-orcid":false,"given":"Teresa","family":"Demarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N","family":"Berdella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.05.008_bib0001","series-title":"Cystic fibrosis foundation patient registry 2021 annual data report","year":"2022"},{"issue":"12","key":"10.1016\/j.jcf.2023.05.008_bib0002","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ppul.23884","article-title":"Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: a longitudinal analysis","volume":"52","author":"McGarry","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2023.05.008_bib0003","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201711-2357OC","article-title":"Disparities in mortality of Hispanic patients with cystic fibrosis in the United States: a national and regional cohort study","volume":"198","author":"Rho","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.05.008_bib0004","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","author":"McGarry","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2023.05.008_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jgc4.1271","article-title":"The CFTR variant profile of Hispanic patients with cystic fibrosis: impact on access to effective screening, diagnosis, and personalized medicine","volume":"29","author":"Januska","year":"2020","journal-title":"J Genet Couns"},{"issue":"19","key":"10.1016\/j.jcf.2023.05.008_bib0006","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 Study Group. Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.008_bib0007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1164\/rccm.200502-273OC","article-title":"Clinical trial participants compared with nonparticipants in cystic fibrosis","volume":"173","author":"Goss","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2023.05.008_bib0008","first-page":"1721","article-title":"Minorities are underrepresented in clinical trials of pharmaceutical agents for cystic fibrosis","volume":"13","author":"McGarry","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.jcf.2023.05.008_bib0009","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMc1916747","article-title":"Triple therapy for cystic fibrosis with a Phe508del CFTR mutation","volume":"382","author":"McGarry","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcf.2023.05.008_bib0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMc1916747","article-title":"Triple therapy for cystic fibrosis with a Phe508del CFTR mutation: reply","volume":"382","author":"Jain","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.008_bib0011","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/S1569-1993(22)01045-1","article-title":"Investigating disparities in cystic fibrosis clinical trial participation: one cystic fibrosis center's self-study","volume":"21","author":"Januska","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.05.008_bib0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jncimonographs\/lgi041","article-title":"Race and ethnicity: comparing medical records to self-reports","volume":"35","author":"West","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"10.1016\/j.jcf.2023.05.008_bib0013","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1475-6773.2007.00771.x","article-title":"Agreement between self-reported and administrative race and ethnicity data among Medicaid enrollees in Minnesota","volume":"42","author":"McAlpine","year":"2007","journal-title":"Health Serv Res"},{"issue":"6","key":"10.1016\/j.jcf.2023.05.008_bib0014","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11606-014-3102-8","article-title":"Accuracy of race, ethnicity, and language preference in an electronic health record","volume":"30","author":"Klinger","year":"2015","journal-title":"J Gen Intern Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:33:42Z","timestamp":1751582022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323001388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1569199323001388"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.05.008","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}